Business Description
Telcon RF Pharmaceutical Inc
ISIN : KR7200230001
Compare
Compare
Traded in other countries / regions
200230.Korea IPO Date
2014-11-24Description
Telcon RF Pharmaceutical Inc manufactures wireless communication equipment. It is engaged in developing connectors for input and output port, board to board, cable assembly, and board to mount used in wireless communication equipment. The company also supply's RF coaxial connectors.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.38 | |||||
| Equity-to-Asset | 0.74 | |||||
| Debt-to-Equity | 0.26 | |||||
| Debt-to-EBITDA | 1.46 | |||||
| Interest Coverage | 1.6 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 0.45 | |||||
| Beneish M-Score | -0.91 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -5.8 | |||||
| 3-Year FCF Growth Rate | -8.4 | |||||
| 3-Year Book Growth Rate | -3.6 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 63.14 | |||||
| 9-Day RSI | 55.54 | |||||
| 14-Day RSI | 52.85 | |||||
| 6-1 Month Momentum % | 20.85 | |||||
| 12-1 Month Momentum % | -26.12 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.94 | |||||
| Quick Ratio | 0.8 | |||||
| Cash Ratio | 0.3 | |||||
| Days Inventory | 72.56 | |||||
| Days Sales Outstanding | 64.66 | |||||
| Days Payable | 36.91 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -8.5 | |||||
| Shareholder Yield % | 12.84 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 26.41 | |||||
| Operating Margin % | 2.66 | |||||
| Net Margin % | 38.3 | |||||
| FCF Margin % | -8.35 | |||||
| ROE % | 13.13 | |||||
| ROA % | 10.01 | |||||
| ROIC % | 0.7 | |||||
| ROC (Joel Greenblatt) % | 87.03 | |||||
| ROCE % | 13.62 | |||||
| Years of Profitability over Past 10-Year | 3 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 5.99 | |||||
| PE Ratio without NRI | 6.71 | |||||
| Price-to-Owner-Earnings | 9.53 | |||||
| PS Ratio | 2.36 | |||||
| PB Ratio | 0.81 | |||||
| Price-to-Tangible-Book | 1.03 | |||||
| EV-to-EBIT | 7.05 | |||||
| EV-to-EBITDA | 5.46 | |||||
| EV-to-Revenue | 2.82 | |||||
| EV-to-FCF | -32.91 | |||||
| Price-to-Projected-FCF | 1.9 | |||||
| Price-to-Graham-Number | 0.55 | |||||
| Earnings Yield (Greenblatt) % | 14.18 | |||||
| FCF Yield % | -3.54 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Telcon RF Pharmaceutical Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 36,307.203 | ||
| EPS (TTM) (â‚©) | 128 | ||
| Beta | 1.77 | ||
| Volatility % | 61.73 | ||
| 14-Day RSI | 52.85 | ||
| 14-Day ATR (â‚©) | 42.743416 | ||
| 20-Day SMA (â‚©) | 763.25 | ||
| 12-1 Month Momentum % | -26.12 | ||
| 52-Week Range (â‚©) | 625 - 1280 | ||
| Shares Outstanding (Mil) | 111.88 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Telcon RF Pharmaceutical Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Telcon RF Pharmaceutical Inc Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Telcon RF Pharmaceutical Inc Frequently Asked Questions
What is Telcon RF Pharmaceutical Inc(XKRX:200230)'s stock price today?
The current price of XKRX:200230 is â‚©766.00. The 52 week high of XKRX:200230 is â‚©1280.00 and 52 week low is â‚©625.00.
When is next earnings date of Telcon RF Pharmaceutical Inc(XKRX:200230)?
The next earnings date of Telcon RF Pharmaceutical Inc(XKRX:200230) is .
Does Telcon RF Pharmaceutical Inc(XKRX:200230) pay dividends? If so, how much?
Telcon RF Pharmaceutical Inc(XKRX:200230) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers